Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harsh Mathur

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of the Egyptian National Cancer Institute|March 16, 2016
Management of uveal tract melanoma: A comprehensive reviewAkhil Kapoor, Vimla Beniwal, Surender Beniwal, et al.
Indian Journal of Ophthalmology|June 6, 2015
Isolated clival metastasis as the cause of abducens nerve palsy in a patient of breast carcinoma: A rare case reportAkhil Kapoor, Vimla Beniwal, Surender Beniwal, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2014
Heterologous expression of thuricin CD immunity genes in Listeria monocytogenesHarsh Mathur, Paula M O'Connor, Paul D Cotter, et al.
Gut Pathogens|June 4, 2016
The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cellsHarsh Mathur, Mary C Rea, Paul D Cotter, et al.
Gut Microbes|January 8, 2015
The potential for emerging therapeutic options for Clostridium difficile infectionHarsh Mathur, Mary C Rea, Paul D Cotter, et al.
Current Protein & Peptide Science|June 3, 2015
The sactibiotic subclass of bacteriocins: an updateHarsh Mathur, Mary C Rea, Paul D Cotter, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinationsHarsh Mathur, Paula M O'Connor, Colin Hill, et al.
Methodsx|April 14, 2025
OPTIMATRIX v2.0: Optimised protocol to mitigate microbial blooms in the micro-Matrix bioreactor platform used as an <i>ex vivo</i> human distal colon modelArghya Mukherjee, Nicola Ferremi Leali, Elisa Salvetti, et al.
Frontiers in Microbiology|July 15, 2017
Bacteriocin-Antimicrobial Synergy: A Medical and Food PerspectiveHarsh Mathur, Des Field, Mary C Rea, et al.
NPJ Biofilms and Microbiomes|May 1, 2018
Fighting biofilms with lantibiotics and other groups of bacteriocinsHarsh Mathur, Des Field, Mary C Rea, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of the Egyptian National Cancer Institute|March 16, 2016
Management of uveal tract melanoma: A comprehensive reviewAkhil Kapoor, Vimla Beniwal, Surender Beniwal, et al.
Indian Journal of Ophthalmology|June 6, 2015
Isolated clival metastasis as the cause of abducens nerve palsy in a patient of breast carcinoma: A rare case reportAkhil Kapoor, Vimla Beniwal, Surender Beniwal, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2014
Heterologous expression of thuricin CD immunity genes in Listeria monocytogenesHarsh Mathur, Paula M O'Connor, Paul D Cotter, et al.
Gut Pathogens|June 4, 2016
The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cellsHarsh Mathur, Mary C Rea, Paul D Cotter, et al.
Gut Microbes|January 8, 2015
The potential for emerging therapeutic options for Clostridium difficile infectionHarsh Mathur, Mary C Rea, Paul D Cotter, et al.
Current Protein & Peptide Science|June 3, 2015
The sactibiotic subclass of bacteriocins: an updateHarsh Mathur, Mary C Rea, Paul D Cotter, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinationsHarsh Mathur, Paula M O'Connor, Colin Hill, et al.
Methodsx|April 14, 2025
OPTIMATRIX v2.0: Optimised protocol to mitigate microbial blooms in the micro-Matrix bioreactor platform used as an <i>ex vivo</i> human distal colon modelArghya Mukherjee, Nicola Ferremi Leali, Elisa Salvetti, et al.
Frontiers in Microbiology|July 15, 2017
Bacteriocin-Antimicrobial Synergy: A Medical and Food PerspectiveHarsh Mathur, Des Field, Mary C Rea, et al.
NPJ Biofilms and Microbiomes|May 1, 2018
Fighting biofilms with lantibiotics and other groups of bacteriocinsHarsh Mathur, Des Field, Mary C Rea, et al.
Pageof 4